Arca
Skip to content
Tools
Tools

Tina-Quant Hemoglobin A1C GEN.2 Test System

Assay, Glycosylated Hemoglobin. 510(k) K072714, from Roche Diagnostics Corp. (Indianapolis, IN). Product code LCP, class 2.

As of Nov 19, 2026, K072714 is an FDA 510(k) held by Roche Diagnostics Corp., substantially equivalent on Apr 18, 2008 after 206 days, with 1 recall tied to it in FDA's recall database.

  • Review time: 206 days
  • Recalls: 1
  • Cited as a predicate by: 2 devices

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

evice Name: Tina-Quant® Hemoglobin A1c Gen.2 Test System Indication For Use: For the quantitative determination of percent hemoglobin A1c in whole blood (or hemolysate derived from whole blood) on Roche clinical chemistry analyzers. HbA1c determinations are useful for monitoring of long-term blood glucose control in individuals with diabetes mellitus.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a predicate

2 later 510(k) summaries name this device as a predicate

Recalls

Recalls FDA ties to K072714, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record
StartedRecallStatus
Oct 4, 2016Z-0395-2017Roche Diagnostics has confirmed elevated QC and patient sample recovery for individual Tina-quant Hemoglobin A1c Gen.2 and Tina-quant Hemoglobin A1cDx Gen.2 cassettes/bottles. This issue occurred over multiple lots.…Terminated

Other LCP clearances

The newest 510(k)s for the same product code; see every LCP device

Record

Type
Special
Received
Sep 25, 2007
Review panel
Hematology
Regulation
21 CFR 864.7470

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.